Showing results (1841-1850 of 2,184) with videos related to
Sort By:
Pageof 219
Nature Genetics|October 11, 2016
Common variants at PVT1, ATG13-AMBRA1, AHI1 and CLEC16A are associated with selective IgA deficiencyPaola G Bronson, Diana Chang, Tushar Bhangale, et al.Radiology|July 24, 2019
Reproducibility and Changes in Vena Caval Blood Flow by Using 4D Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease (COPD): The Multi-Ethnic Study of Atherosclerosis (MESA) COPD SubstudyOzair Rahman, Michael Markl, Pallavi Balte, et al.American Journal of Respiratory Cell and Molecular Biology|June 28, 2018
Whole-Genome Sequencing in Severe Chronic Obstructive Pulmonary DiseaseDmitry Prokopenko, Phuwanat Sakornsakolpat, Heide Loehlein Fier, et al.Bioactive Materials|December 11, 2024
Rapid assessment of the osteogenic capacity of hydroxyapatite/aragonite using a murine tibial periosteal ossification modelEmma Steijvers, Yunshong Shi, Hong Lu, et al.Annals of the American Thoracic Society|August 15, 2022
Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary DiseaseAparna Balasubramanian, Nirupama Putcha, Neil R MacIntyre, et al.Plos Genetics|February 1, 2012
High-density SNP mapping of the HLA region identifies multiple independent susceptibility loci associated with selective IgA deficiencyRicardo C Ferreira, Qiang Pan-Hammarström, Robert R Graham, et al.Genes and Immunity|March 19, 2018
Previously reported placebo-response-associated variants do not predict patient outcomes in inflammatory disease Phase III trial placebo armsAsher Haug-Baltzell, Tushar R Bhangale, Diana Chang, et al.Journal of Global Health|January 12, 2026
Outcome and management of 2-59-month-old Nigerian children with chest indrawing pneumonia at primary-level healthcare facilities: a prospective cohort studyAdegoke G Falade, Obioma C Uchendu, Ayobami A Bakare, et al.Thorax|January 29, 2017
Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA studyAnna J Podolanczuk, Ganesh Raghu, Michael Y Tsai, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 17, 2015
Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPDDavid M Mannino, Ruth Tal-Singer, David A Lomas, et al.Pageof 219